Are you interested in exploring the latest innovations in the biotech and pharma sector, with an eye to environmental sustainability? Join our webinar dedicated to professionals and professionals in the fields of Cell Factory, Biotech, pharma and hospital. A unique opportunity to explore the ecological impact of ATMP manufacturing, compare innovative technologies and discuss European regulations in favor of sustainability.

Register

Target group

The webinar is aimed at all stakeholders and especially people working in the fields of Cell Factory, Biotech , pharma and hospitals.

What we learn from the course

During the meeting will be proposed ideas for reflection on the assessment of the ecological impact and environmental sustainability. In particular, through the sharing of experiences, ATMP manufacturing issues will be addressed in the comparison between the traditional cell factory and cell factory that uses innovative technology such as closed systems.
Then there will be ideas for reflection on how fundamental is the use, also in the health sector, of sustainable products. In this regard, we will talk about the European regulation that encourages companies to take sustainable measures and the prohibition of the use of formaldehyde.

Program

• Description of entrepreneurial paths as a virtuous example of companies that have invested in the development of a sustainable product.
• GMP Regulatory Scope for ATMP.
• Definition Open and closed systems for ATMP manufacturing.
• Open system comparison (ainb) vs Closed AinD.
• Environmental sustainability in ATMP manufacturing in closed systems.
• Outline of European regulations that guide business choices towards a greater commitment to sustainability.

Lecturers

• Avv. Giorgia Pansa. He is a lawyer and, since 2020, he actively collaborates with Addax Biosciences, taking care of the communication activities of the project, whose objective is to safeguard the health of workers professionally exposed to formalin, aiming to replace the carcinogen with a safe and sustainable fixative.
• Doct. Cristina Zanini. After graduating in Chemistry and a Master in Clinical Biochemistry and Molecular Medicine (2003), he obtained a doctorate in Biochemistry and Cellular Biotechnology (University of Turin, 2007). Head of a Research and Development laboratory located within the University of Turin; he is also a contact person for the organization of training, workshops, webinars and scientific meetings in the field of ATMP. She has published more than 20 articles and is the author of 4 different patents presented in collaboration with the University of Turin, Euroclone and bioair.

Register